Konferenzposter

A pseudopeptide xenin analogue augments the metabolic benefits of sitagliptin effectiveness in high-fat-fed mice


AutorenlisteGault, V.A.; Craig, S.L.; Hamscher, G.; McClean, S.; Irwin,N.

Jahr der Veröffentlichung2020

Seiten53-53

ZeitschriftDiabetic Medicine

Bandnummer37

HeftnummerSuppl. 1

DOI Linkhttps://doi.org/10.1111/dme.16_14245

KonferenzDiabetes UK Professional Conference

VerlagWiley



Autoren/Herausgeber




Zitierstile

Harvard-ZitierstilGault, V., Craig, S., Hamscher, G., McClean, S. and Irwin, N. (2020) A pseudopeptide xenin analogue augments the metabolic benefits of sitagliptin effectiveness in high-fat-fed mice [Poster], Diabetic Medicine, 37(Suppl. 1), Article P86, p. 53. https://doi.org/10.1111/dme.16_14245

APA-ZitierstilGault, V., Craig, S., Hamscher, G., McClean, S., & Irwin, N. (2020). A pseudopeptide xenin analogue augments the metabolic benefits of sitagliptin effectiveness in high-fat-fed mice. Diabetic Medicine. 37(Suppl. 1), Article P86, 53. https://doi.org/10.1111/dme.16_14245


Zuletzt aktualisiert 2025-21-05 um 16:09